Altogen Labs CRO Services:
- PRE-CLINICAL RESEARCH SERVICES
- Pharmacology and Toxicology Testing: IC50 for Tumor Cell Lines
- Xenograft Animal Service: Immunocompromised NOD/SCID Mice
- Therapeutic RNAi Development: Targeted siRNA, qPCR Assays
- Liposome Encapsulation Services: siRNA, miRNA, DNA, Proteins
- ELISA and Cell-Based Assay Development (Cell Cycle, Viability)
- Apoptosis Assay: Caspase-3 and Caspase-7 Cell Line Screen
- RNAi Consulting: Technology Development and Evaluation
- GENERATION OF STABLE CELL LINES
- CELL BANKING SERVICES
- RNA INTERFERENCE (RNAi) SERVICES
- In Vivo siRNA Delivery and Tissue Targeting (In Vivo RNAi)
- siRNA Transfection and RNAi Cell-based Library Screening
- Generation of Tet-inducible RNAi Gene Knockdown Cell Lines
- RNAi Screen Pathway Analysis: siRNA and microRNA
- RNAi Manufacturing and CRO Services
- PCR Cloning: DNA Vector Construction (shRNA)
- Quantitation sh/siRNA-induced Knockdown by qRT-PCR and WB
- Genome-wide siRNA and microRNA High-throughput Screens
- Stable RNAi Cell Line Generation: Stable Gene Knockdown
- siRNA Liposome Encapsulation Service
- Transient (siRNA) and Stable (shRNA) Transfection Services
- BIOLOGY LABORATORY CRO SERVICES
- BIOREMEDIATION SERVICES
- MICROORGANISM ID SERVICE
News
Altogen Labs Offers Pre-Clinical CRO Services to Accelerate Pre-Clinical Research Needs /26.04.2013
GLP compliant laboratory provides preclinical research and biology contract research services (CRO) to pharma, biotechnology companies, universities, and cancer research centers worldwide. Our services include xenograft, pharmacology and toxicology assays (IC50), cell banking, generation of stable cell lines, RNAi gene silencing and other invivo and invitro services. Read
Altogen Labs Announces Patent Filing for Bioremediation Process and Oil Spill Cleanup Products /26.10.2012
Altogen Labs announced the filing of a patent for bioremediation microorganism isolation and selection methods (USPTO application 13/490,508). This environmental technology is based on isolation of naturally present microorganisms in heavily contaminated soil, which allows accelerating natural bioremediation processes. Read
Altogen Labs Microorganism ID: Bacteria Identification Service /24.05.2012
Altogen Labs announced its launch of microorganism ID bacteria identification service, providing over 100 primer sets for 16S rDNA gene sequencing and follow up bioinformatic sequence characterization. Service enables identification of over 5,000 species of bacteria and various other microorganisms present in environmental or clinical samples Read
Altogen Labs Launches In Vivo siRNA Liposome Encapsulation Services /12.12.2011
Altogen Labs launched siRNA liposome encapsulation service, a laboratory technique to enable in vivo delivery of siRNA. Liposome encapsulation platform uses latest microfluidizer (Microfluidics) technology and is unique in its ability to achieve liposomal protection of functional siRNA molecules, provide uniform target particle sizes, and enhance siRNA transfection efficiency in vivo Read
Altogen Labs Company Profile /08.11.2011
Altogen Labs, a GLP-compliant laboratory located in Austin, Texas (USA), provides pharmacology and biotechnology contract research services (CRO). Company offers innovative life science research services, including a variety of pre-clinical studies, development of stable cell lines, in vivo biodistribution, xenograft and RNAi gene silencing services - siRNA encapsulation, targeting Read
Altogen Labs Launches Pyrosequencing Services /19.07.2011
Altogen Labs, a biology contract research organization and provider of pre-clinical research services, announced its launch of a pyrosequencing service today. Based on the new PyroMark platform, the pyrosequencing service is a multi-application genetic analysis tool Read
Texas-Based Biotechnology Company Develops Oil-Degrading Bacteria /24.10.2010
Altogen Labs announced today that it has successfully isolated natural oil-eating bacteria from polluted soil near Galveston Bay, Texas that has been shown in laboratory tests to be effective for the bioremediation of crude oil and petroleum saturated earth. Read
PEG-Liposome siRNA In Vivo Transfection Kit From Altogen /21.10.2010
Altogen announced the release of its second generation of in vivo RNAi transfection reagent in the company's popular in vivo delivery product line: PEG-Liposome siRNA In Vivo Transfection Kit. This reagent is compatible for in vivo transfection of other negatively charged molecules – RNA, DNA, and small proteins. The company also offers custom encapsulation of target molecules Read
Altogen Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services /11.03.2010
Altogen announced launch of new contract research services. Altogen custom services focus on providing specialized biotechnology and pharmaceutical services, including RNA Interference (RNAi) services, generation of stably-expressing cell lines, screening and transfection services Read
Altogen Launches Nanoparticle-based In Vivo Transfection Reagent /03.11.2009
Altogen announced launch of novel Nanoparticle-based transfection reagent for use in laboratories and research facilities for animal testing. Transfection is one of the major laboratory methods used to introduce DNA and RNA molecules into cells and tissues Read